NL-OMON55145招募中不适用
*Evaluation of biomarkers in VTE study with capillary blood sample; the EVA-II study* - EVA-II
Jeroen Bosch Ziekenhuis0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •-Patients with suspected Venous ThromboEmbolism, in whom the GP orders a
- •D-dimer test
- •-Life expectancy more than 3 months
排除标准
- •Exclusion criteria are age below 18; anticoagulant treatment (vitamin K, NOAC,
- •low molecular-weight heparin) for other causes than VTE; pregnancy or a life
- •expectancy less than three months. Unwilling to participate in this study.
研究者
相似试验
招募中
不适用
'Evaluatie van biomarkers in VTE studie met capillair bloed monster; de EVA-II studie'NL-OMON26166Jeroen Bosch Hospital350
招募中
不适用
Evaluatie van biomarkers bij VTE onderzoek; de EVA studieDeep Venous Thrombosis, Pulmonary Embolism, D-dimer, Point-of-Care biomarker, primary careNL-OMON29132niversity Medical Center Utrecht750
尚未招募
不适用
Evaluation of biomarkers in VTE study: the EVA study.venous thrombosis pulmonary embolism10014523NL-OMON46107niversitair Medisch Centrum Utrecht
招募中
不适用
Investigation of clinical biomarkers reflecting the neurological basis of depressive symptoms and their usefulness in novel therapeutic techniquedepressive symptomsJPRN-UMIN000026411Gunma University210
招募中
不适用
An exploratoly study to evaluate biomarkers in cell free DNA of "Sequential therapy from afatinib to osimertinib for EGFR mutant non small cell lung cancer: a multicenter prospective observational study (Gio Tag Japan)".non-small cell lung cancer(EGFR mutation positive)JPRN-UMIN000043235HANSHIN Oncology Group93
